{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:11:48Z","timestamp":1785564708192,"version":"3.56.0"},"reference-count":10,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":351,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1111\/all.12494","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T07:46:54Z","timestamp":1406533614000},"page":"1560-1563","source":"Crossref","is-referenced-by-count":13,"title":["Management of hypersensitivity reactions to anti-D immunoglobulin preparations"],"prefix":"10.1111","volume":"69","author":[{"given":"K.","family":"Rutkowski","sequence":"first","affiliation":[{"name":"Allergy Department; Cambridge University Hospitals NHS Foundation Trust; Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Nasser","sequence":"additional","affiliation":[{"name":"Allergy Department; Cambridge University Hospitals NHS Foundation Trust; Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,15]]},"reference":[{"key":"10.1111\/all.12494-BIB0001|all12494-cit-0001","unstructured":"UK National Institute for Health and Care Excellence Routine antenatal anti-D prophylaxis for women who are rhesus D negative. Technology Appraisal 158 2008"},{"key":"10.1111\/all.12494-BIB0002|all12494-cit-0002","unstructured":"Rhophylax SNP www.medicines.org.uk\/emc\/medicine\/12087\/SPC\/Rhophylac+300+%281500+IU%29"},{"key":"10.1111\/all.12494-BIB0003|all12494-cit-0003","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/bmj.330.7502.1255","article-title":"Management of pregnancies with RhD alloimmunisation","volume":"330","author":"Kumar","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/all.12494-BIB0004|all12494-cit-0004","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.transci.2014.02.008","article-title":"Noninvasive fetal RhD genotyping","volume":"50","author":"Clause","year":"2014","journal-title":"Transfus Apheres Sci"},{"key":"10.1111\/all.12494-BIB0005|all12494-cit-0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2012.06.035","article-title":"Anaphylaxis during pregnancy","volume":"130","author":"Simons","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12494-BIB0006|all12494-cit-0006","first-page":"1","article-title":"Births: final data for 2003","volume":"54","author":"Martin","year":"2005","journal-title":"Natl Vital Stat Rep"},{"key":"10.1111\/all.12494-BIB0007|all12494-cit-0007","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1182\/asheducation-2013.1.283","article-title":"Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?","volume":"1","author":"Despotovic","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1111\/all.12494-BIB0008|all12494-cit-0008","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2222.1988.tb02902.x","article-title":"Anaphylactoid reaction after injection of anti-rhesus-D-hyperimmunoglobulin","volume":"18","author":"Ring","year":"1988","journal-title":"Clin Allergy"},{"key":"10.1111\/all.12494-BIB0009|all12494-cit-0009","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1398-9995.1995.tb02511.x","article-title":"Urticaria from allergy to a purified human anti-Rh antibody preparation","volume":"50","author":"Sulakvelidze","year":"1995","journal-title":"Allergy"},{"key":"10.1111\/all.12494-BIB0010|all12494-cit-0010","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","article-title":"Effect of high through-put RHD typing of fetal DNA in maternal plasma on use of anti-RhD negative pregnant women: prospective feasibility study","volume":"12","author":"Finning","year":"2008","journal-title":"BMJ"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.12494","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T17:23:51Z","timestamp":1498152231000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/all.12494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,15]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1111\/all.12494","relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,15]]}}}